https://orcid.org/0000-0003-3340-5031
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Recurrent aphthous stomatitis (RAS) refers to a sore and frequently recurring inflammation of the oral tissues, distinguished by the presence of small ulcers that cause significant discomfort and cannot be attributed to any underlying disease. Different treatments have been used for RAS. This review aims to provide a comprehensive overview of the treatment options over the past decade for recurrent aphthous stomatitis (RAS), encompassing both natural and synthetic treatments. It will utilize clinical efficacy studies conducted in vivo and in vitro, along with a focus on the pharmaceutical approach through advancements in drug delivery development. We conducted a thorough literature search from 2013 to 2023 in prominent databases such as PubMed, Scopus, and Cochrane, utilizing appropriate keywords of recurrent aphthous stomatitis, and treatment. A total of 53 clinical trials with 3022 patients were included, with 35 using natural materials in their research and a total of 16 articles discussing RAS treatment using synthetic materials. All the clinical trials showed that natural and synthetic medicines seemed to benefit RAS patients by reducing pain score, ulcer size, and number of ulcers and shortening the healing duration.
Abbreviations
RAS, Recurrent Aphthous Stomatitis; CMV, Cytomegalovirus; NAC, N-Acetylcysteine; VAS, Visual Analog Scale; AlMgS, Aluminum Magnesium Simethicone; NSAID, Non-steroidal Anti-inflammatory Drug; RCT, Randomized Controlled Trial; QD, Once a day; BID, Twice a day; TID, Thrice a day; QID, 4 times a day.
Acknowledgments
We would like to thank The Rector of Universitas Padjadjaran for the APC.
Disclosure
The authors report no conflicts of interest in this work.